Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026 
F-star Therapeutics Reports Full-Year 2020 Financial Results and Provides Corporate Update
Company to Host Conference Call Today at 9 a.m. EDTCAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 29, 2021 (GLOBE NEWSWIRE)...
Escher Biomedical Diagnostics Announces BT-MED® COV19 Test for Detection of COVID-19 Virus Infection in Saliva Samples
AUSTIN, Texas, March 29, 2021 (GLOBE NEWSWIRE) -- Escher Biomedical Diagnostics, LLC announced that its Escher BT-MED® COV19 Saliva Test...
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
85,000 square foot state-of-the-art facility being built in Rockville, MarylandAccelerates TCR2’s commercial-scale manufacturing timelines with production anticipated in 2023Aaron Vernon...
Cynata Expands MEND clinical trial in COVID-19 and Respiratory Failure
MELBOURNE, Australia, March 29, 2021 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell...
Philip J. Facchina, Chief Strategy Officer and Principal of SurgCenter Development, Joins Mesoblast Board
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
ORYZON Enrolls First Patient in PORTICO, a Phase IIb Clinical Trial With Vafidemstat in Borderline Personality Disorder
Global Phase IIb adaptive trial recruiting patients in Europe and the U.S.The first interventional clinical trial in a real-world Borderline...
BetterLife Added to Horizons Psychedelic Stock Index ETF
Announces Closing of Non-Brokered Private PlacementVANCOUVER, March 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:...
Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations
- Autolus to expand on existing operations in the UK for commercial supply of AUTO1 resulting in a less capital-intensive...
Adagene Announces Clinical Advancement for ADG116
-NEObody™ product candidate ADG116 has been well tolerated in ongoing Phase 1 clinical trial- -Promising pharmacodynamic biomarker signals demonstrate clinical proof...
TG Therapeutics Completes Rolling Submission of Biologics License Application to the U.S. Food and Drug Administration for Ublituximab in Combination with UKONIQ™(umbralisib) as a Treatment for Patients with Chronic Lymphocytic Leukemia
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the completion of the rolling submission...
Aurora Spine receives IRB approval for Multicenter Study of its ZIP® Interspinous Fixation Device for Relief of Back Pain
CARLSBAD, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),...
Verrica Announces Election of Gary Goldenberg, MD, Verrica’s Chief Medical Officer, to Membership in the American Dermatological Association
WEST CHESTER, Pa., March 29, 2021 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (NASDAQ: VRCA), a dermatology therapeutics company developing...
Auxly Receives Conditional Approval to Graduate to the Toronto Stock Exchange
TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) ("Auxly" or the "Company"),...
Avicanna´s Majority Owned Colombian Subsidiary Attains 2021 THC Production Quota and Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Chile
Avicanna has been granted its 2021 quota from the Colombian government to cultivate and process up to 10,267 kg of...
Todos Medical Completes Automation Equipment Installation and Training for a Laboratory Client in Brooklyn, NY
· Automation solution increases processing capacity to 6,000 PCR tests per day, expandable to 12,000 daily tests with minor upgrades · Client...
Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders
SALT LAKE CITY, March 29, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and...
Algernon Pharmaceuticals Announces its Addition to the Market’s First Psychedelic Stock Index ETF
VANCOUVER, British Columbia., March 29, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Precision BioSciences to Participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Day
DURHAM, N.C., March 29, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic...
Psirenity granted approval to conduct Jamaica’s first psilocybin clinical trial to help manage depression
TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Psirenity, a wholly owned subsidiary of New Leaf Canada Inc., today announced it...
Clene Reports Full Year 2020 Operating and Financial Highlights
Interim Phase 2 data indicate that CNM-Au8 has a homeostatic effect on brain bioenergetics Topline data from a Phase 2...